Circulating levels of chondroitin/dermatan sulfate (CS/DS) and heparan sulfate/heparin (HS/H) in healthy subjects and patients with rheumatoid arthritis (RA) before and after 15-month anti-TNF-α therapy. This evidence concerns the gene TNF and rheumatoid arthritis.